Product logins

Find logins to all Clarivate products below.


Pulmonology Devices | Market Insights | US | 2024

The US pulmonology device market was negatively impacted by the COVID-19 pandemic. However, overall pulmonology procedure volumes will continue to grow moderately over the forecast period, fueled by bronchoscopy and bronchial biopsy procedure volume growth, favorable demographic trends, and the adoption of premium-priced technologies, particularly in the bronchoscope market. However, a lack of product innovation in some segments such as foreign body removal devices will limit growth opportunities of the US pulmonology device market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for pulmonology devices in the US from 2019 through 2032.

Related Medtech Insights Reports

Report
Small-Joint Reconstructive Implants | Market Insights | Latin America (Supplemental) | 2024
The Latin American small-joint reconstructive implant market is significantly underpenetrated when compared to the US and European markets, providing ample room for expansion. The adoption of…
Report
Pain Management Devices | Medtech Insights | Europe | 2024
Following the recovery from the impact of the COVID-19 pandemic, the European pain management device market will see moderate growth through 2032. Manufacturers in this space are actively…
Report
Neurostimulation Devices | Market Insights | Europe | 2024
Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
Report
Pain Management Devices | Medtech Insights | Europe | 2023
The COVID-19 pandemic significantly impacted the European pain management device market in 2020 and 2021 because the associated procedures were deemed nonurgent and consequently were postponed at…
Report
Vascular Access Devices – Market Insights – United States
The US vascular access device market will grow slowly over the forecast period. On one hand, unit sales will be supported by steady growth in the underlying patient population undergoing medical…